Dr. Reddy's Laboratories Limited Stock NSE India S.E.
Stocks
INE089A01031
Pharmaceuticals
| Market Cap | 1,024B 10.64B 9.27B 8.56B 7.85B 14.93B 15.2B 102B 40.07B 500B 39.95B 39.08B 1,723B | P/E 2027 * |
24.4x | P/E 2028 * | 19.5x |
|---|---|---|---|---|---|
| Enterprise Value | 991B 10.3B 8.97B 8.29B 7.6B 14.45B 14.71B 98.74B 38.79B 484B 38.68B 37.83B 1,668B | EV / Sales 2027 * |
2.79x | EV / Sales 2028 * | 2.46x |
| Free-Float |
70.07% | Yield 2027 * |
0.63% | Yield 2028 * | 0.68% |
Last Transcript: Dr. Reddy's Laboratories Limited
| Manager | Title | Age | Since |
|---|---|---|---|
Erez Israeli
CEO | Chief Executive Officer | 59 | 2019-06-30 |
| Director of Finance/CFO | - | 2024-07-31 | |
Sanjay Sharma
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 58 | 2014-05-12 | |
Gunupati Prasad
CHM | Chairman | 65 | 2013-04-01 |
Leo Puri
BRD | Director/Board Member | 65 | 2018-10-24 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 10.8B | |
| +0.35% | -6.39% | +44.70% | +157.34% | 1,028B | |
| -2.69% | -7.57% | +57.52% | +54.51% | 611B | |
| +0.44% | -4.14% | +27.46% | +79.48% | 432B | |
| +0.98% | -2.74% | +28.13% | +21.76% | 323B | |
| -0.34% | -3.79% | +26.52% | +43.60% | 277B | |
| +1.63% | -12.52% | +17.86% | +21.72% | 257B | |
| +3.39% | +0.95% | -25.43% | -37.83% | 217B | |
| +0.86% | -2.66% | +20.63% | +57.55% | 192B | |
| +1.28% | -3.42% | +17.49% | +70.62% | 161B | |
| Average | +0.90% | -5.24% | +23.88% | +52.08% | 388.7B | |
| Weighted average by Cap. | +0.68% | -5.52% | +32.95% | +76.70% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 356B 3.7B 3.22B 2.97B 2.73B 5.19B 5.28B 35.45B 13.92B 174B 13.88B 13.58B 599B | 395B 4.1B 3.57B 3.3B 3.03B 5.75B 5.86B 39.3B 15.44B 193B 15.4B 15.06B 664B |
| Net income | 42.23B 439M 382M 353M 324M 616M 627M 4.21B 1.65B 20.64B 1.65B 1.61B 71.07B | 53.11B 552M 481M 444M 407M 774M 788M 5.29B 2.08B 25.96B 2.07B 2.03B 89.38B |
| Net Debt | -32.67B -339M -296M -273M -251M -476M -485M -3.25B -1.28B -15.96B -1.27B -1.25B -54.97B | -54.24B -564M -491M -453M -416M -791M -805M -5.4B -2.12B -26.51B -2.12B -2.07B -91.28B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Choose MarketScreener 
